United States

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

26 Apr 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

More From Around the Web

Name Age Since Current Position

Deepak Parekh

72 Non-Executive Chairman of the Board

Andrew Aristidou

2014 Chief Financial Officer, Executive Director

D. Bartaria

2015 Executive Vice President– Pharmaceuticals

H. Buch

2012 Executive Vice President - Pharmaceuticals

Ajay Nadkarni

2011 Compliance Officer, Company Secretary, General Manager - Administration